Donor phosphorus levels and recipient outcomes in living-donor kidney transplantation

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1179-1184

  Chang, Peter C ^a   Saha, Sharmeela ^b   Gomes, Amanda M ^b   Padiyar, Aparna ^b   Bodziak, Kenneth A ^b   Poggio, Emilio D ^c   Hricik, Donald E ^b   Augustine, Joshua J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Department of Nephrology and Hypertension   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHORUS; TACROLIMUS;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; RENAL GRAFT DYSFUNCTION; RISK FACTOR; SEX DIFFERENCE;

ACUTE DISEASE; ADULT; AFRICAN AMERICANS; BIOLOGICAL MARKERS; CREATININE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PHOSPHORUS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79957872389     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03220410     Document Type: Article

References (31)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patientson dialysis, patients on dialysis awaiting transplantation,and recipients of a first cadaveric transplant. N EnglJ Med 341: 1725-1730, 1999
2. United Network For Organ Sharing. Available at: http://www.unos.org. Accessed 2010.
3. United States Renal Data System: Volume Two: Atlas of End-Stage Renal Disease. Available at: e-linkurlhttp://www.usrds.org/2009/pdf/V2-07-09.PDF/url/e-link. Accessed 2010.
4. Toma T, Tanabe K, Tokumoto T, Shimizu T, Shimmura H: Time-dependent risk factors influencing the long-term outcomein living renal allografts: Donor age is a crucial riskfactor for long-term graft survival more than 5 years aftertransplantation. Transplantation 72: 940-947, 2001
5. Oien CM, Reisoeter AV, Leivestad T, Dekker FW, Line PD,Os I: Living donor kidney transplantation: The effects of donorage and gender on short- and long-term outcomes. Transplantation83: 600-606, 2007
6. Issa N, Stephany B, Fatica R, Nurko S, Krishnamurthi V, Goldfarb DA, Braun WE, Dennis VW, Heeger PS, Poggio ED: Donor factors influencing graft outcomes in live donor kidneytransplantation. Transplantation 83: 593-599, 2007
7. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Associationof serum phosphorus and calcium X phosphate productwith mortality risk in chronic hemodialysis patients: A nationalstudy. Am J Kidney Dis 31: 607-617, 1998
8. Dhingra R, Sullivan LM, Fox CS, Wang TJ, S'Agostino RB, Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus andcalcium levels to the incidence of cardiovascular disease inthe community. Arch Intern Med 167: 879-885, 2007
9. Larsson TE, Olauson H, Hagstrom E, Ingelsson E, Arnlov J, Lind L, Sundstrom J: Conjoint effects of serum calcium andphosphate on risk of total, cardiovascular, and noncardiovascularmortality in the community. Arterioscler Thromb VascBiol 30: 333-339, 2010
10. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesiclemediatedcalcification in response to changes in extracellularcalcium and phosphate concentrations: A potential mechanismfor accelerated vascular calcification in ESRD. J Am SocNephrol 15: 2857-2867, 2004
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtrationrate. Ann Intern Med 150: 604-612, 2009
12. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y: The Banff 97 working classification of renalallograft pathology. Kidney Int 55: 713-723, 1999
13. Akkina SK, Connaire JJ, Israni AK, Snyder JJ, Matas AJ, Kasiske BL: Similar outcomes with different rates of delayedgraft function may reflect center practice, not center performance.Am J Transplant 9: 1460-1466, 2009
14. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serumphosphorus levels associate with coronary atherosclerosis inyoung adults. J Am Soc Nephrol 20: 397-404, 2009
15. de Boer IH, Rue TC, Kestenbaum B: Serum phosphorus concentrationsin the third National Health and Nutrition ExaminationSurvey (NHANES III). Am J Kidney Dis 53: 399-407,2009
16. Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH, Melamed ML: Serum alkaline phosphatase andphosphate and risk of mortality and hospitalization. ClinJ Am Soc Nephrol 5: 1064-1071, 2010
17. Rush DN, Cockfield SM, Nickerson PW, Arlen DJ, Boucher A, Busque S, Girardin CE, Knoll GA, Lachance JG, Landsberg DN, Shapiro RJ, Shoker A, Yilmaz S: Factors associated withprogression of interstitial fibrosis in renal transplant patientsreceiving tacrolimus and mycophenolate mofetil. Transplantation88: 897-903, 2009
18. Alonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A, Kestenbaum BR, Chambless LE, Jacobs DR Jr: Dietaryphosphorus, blood pressure, and incidence of hypertensionin the atherosclerosis risk in communities study and themulti-ethnic study of atherosclerosis. Hypertension 55: 776-784, 2010
19. Burnett-Bowie SM, Mendoza N, Leder BZ: Effects of gonadalsteroid withdrawal on serum phosphate and FGF-23 levels inmen. Bone 40: 913-918, 2007
20. Gutiérrez OM, Isakova T, Smith K, Epstein M, Patel N, Wolf M: Racial differences in postprandial mineral ion handling inhealth and in chronic kidney disease. Nephrol Dial Transplant 25: 3970-3977, 2010
21. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD: Acute phosphate nephropathy following oral sodium phosphatebowel purgative: An underrecognized cause of chronicrenal failure. J Am Soc Nephrol 16: 3389-3396, 2005
22. Brown SA, Crowell WA, Barsanti JA, White JV, Finco DR: Beneficial effects of dietary mineral restriction in dogs withmarked reduction of functional renal mass. J Am Soc Nephrol1: 1169-1179, 1991
23. Matsuzaki H, Uehara M, Suzuki K, Liu QL, Sato S, Kanke Y, Goto S: High phosphorus diet rapidly induces nephrocalcinosisand proximal tubular injury in rats. J Nutr Sci Vitaminol43: 627-641, 1997
24. Agrawal N, Nair R, McChesney LP, Tuteja S, Suneja M, Thomas CP: Unrecognized acute phosphate nephropathy in akidney donor with consequent poor allograft outcome. Am JTransplant 9: 1685-1689, 2009
25. Scatena M, Liaw L, Giachelli CM: Osteopontin: A multifunctionalmolecule regulating chronic inflammation and vasculardisease. Arterioscler Thromb Vasc Biol 27: 2302-2309, 2007
26. Venuraju SM, Yerramasu A, Corder R, Lahiri A: Osteoprotegerinas a predictor of coronary artery disease and cardiovascularmortality and morbidity. J Am Coll Cardiol 55: 2049-2061, 2010
27. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M: Fibroblast growth factor 23 and mortality amongpatients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
28. El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM: Phosphate feedinginduces arterial medial calcification in uremic mice: Role ofserum phosphorus, FGF-23 and osteopontin. Kidney Int 75:1297-1307, 2009
29. Matsuzaki H, Katsumata S, Uehara M, Suzuki K, Miwa M: High-phosphorus diet induces osteopontin expression of renaltubules in rats. J Clin Biochem Nutr 41: 179-183, 2007
30. Alchi B, Nishi S, Kondo D, Kaneko Y, Matsuki A, Imai N, Ueno M, Iguchi S, Sakatsume M, Narita I, Yamamoto T, Gejyo F: Osteopontin expression in acute renal allograft rejection. Kidney Int 67: 886-896, 2005
31. Rouchop KM, Roelofs JJ, Sylva M, Rowshani AT, Ten Berge IJ, Weening JJ, Floquin S: Renal expression of CD44 correlateswith acute renal allograft rejection. Kidney Int 70:1127-1134, 2006